The view
CRH closed at $93.16 on 13 November 2026, with the share price at −16.9% over the past year and the close at −8.9% from its 200-day average. The Intrinsic Value model puts the company at $85.31 per share, a gap of −8.4%, so intrinsic value sits below the price. The published 21-session view is +0.55%, a slight lean up. The published 63-session view is +0.32%, also a slight lean up. Both readings come in a strong risk-off market regime.
Next month: why the model view is positive
The published 21-session view leans up only barely, at +0.55%, and the probability of a rise is 49%, below even odds. The small positive mean likely reflects a band skewed to the upside, from −15.9% to +17%, rather than a broad expectation of gains. The supporting facts are light short selling, at percentile 19 in the sector, and chart-pattern measures at the highest of the company's own five years. Against them stands the strong risk-off regime. Across 200 past situations like today's, the median move over the next 21 sessions was +1.5% and 56% of them rose. That history leans a little more positive than the published view, but it is history, not a forecast.
Next 3 months: model view positive
The published 63-session view is +0.32%, a modest lean up inside a wide band from −24.1% to +24.8%. It points the same way as the 21-session view, so the two horizons do not conflict here. The facts behind it are a price at −8.9% from its 200-day average yet 18.5% above its 52-week low, which reads as a partial recovery. High filing sentiment and a macro sensitivity reading that is high against other large companies sit alongside it. The past situations like today's had a median 63-session return of +3.1%, and 58% of them rose. That history agrees with the lean and is somewhat firmer than the published figure.
The long term
The long-term case is mixed. Intrinsic value of $85.31 sits below the price, a gap of −8.4%, which weighs against it. The earnings multiple of 15.61 is at percentile 41 in the sector, a little below the middle, and price to book is 2.20. Return on equity of 14.8% is solid. Debt to equity of 0.75 is at percentile 52, mid-sector. A Piotroski score of 6 and operating cash flow of $5.19B point to sound finances, while revenue growth of +3% is modest. Past situations like today's showed a median one-year return of +13.6%, with 70% rising. That history is supportive, while intrinsic value is the main counterweight.
How sure we are
The record on CRH gives the 21-session view some weight. 57% of 283 matured forecasts matched the direction, a little better than the base rate of about half across all names. The history rests on 200 past situations, matched on seven measures rather than the 641 features computed today. The bands are wide, from −15.9% to +17% over 21 sessions and from −24.1% to +24.8% over 63 sessions, and both published means are small against them. That makes each lean a weak, dated reading rather than a firm call.